Pharmafile Logo

dual tasking

- PMLiVE

Lucid Group and Vivid Medical Communications make the cut at this year’s Communiqué awards

Lucid Group has been shortlisted for the Porterhouse Medical Group Award for Medical Consultancy of the Year award, illustrating once again the magic that Lucid brings to the industry.Vivid, a...

Lucid Group Communications Limited

- PMLiVE

Am I wrong to be apprehensive about gene therapy?

Is the introduction of gene therapy going to be smooth sailing? Origin's Strategic Solutions Director, Su Smith, shares her thoughts.

Bedrock Healthcare Communications

Patient Centricity On Trial

Today, 40 million patients are needed for over 300,00 clinical trials, worldwide. This year’s white paper explores how bringing the patient experience front and centre in clinical trials could revolutionise...

Havas Lynx

19 Patient Centricity on Trial

Clinical trials are broken and only patients can help us fix them. If we let them.

Havas Lynx

Novartis day

FDA clears Novartis’ new breast cancer drug Piqray

Blockbuster potential for PI3K drug

- PMLiVE

Resurgent Diurnal raises £5.4m for twin product filings

Company recovers after trial setback

Spotlight on innovation at life sciences forum

Paul Midgley, of Wilmington Healthcare, takes a look at the forthcoming HSJ Life Sciences Forum, where the NHS and industry will unite to discuss challenges and explore innovative solutions

Wilmington Healthcare

Pat Iannuzelli

Porterhouse Medical Group strengthens its US scientific team

The Porterhouse Medical Group announces a senior appointment at Porterhouse Medical US.

Porterhouse Medical Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links